Clinical Trial
doi: 10.1002/cncr.1990.66.s5.1045.
Zoladex and flutamide versus bilateral orchiectomy. A randomized phase III EORTC 30853 study. The EORTC GU Group
Affiliations
- PMID: 2144206
- DOI: 10.1002/cncr.1990.66.s5.1045
Item in Clipboard
Clinical Trial
Zoladex and flutamide versus bilateral orchiectomy. A randomized phase III EORTC 30853 study. The EORTC GU Group
Cancer.
.
Abstract
A total of 327 patients with metastatic prostatic cancer were randomized to either bilateral orchiectomy or treatment with zoladex depot supplemented by flutamide 250 mg 3 qid. Statistically significant increases in time to subjective and objective progression were recorded in favor of the combination treatment. No differences in time to death by cancer or overall death were recorded. The clinical significance of these differences will be reassessed once additional follow-up is available and further analysis of the overall clinical material has been carried out.
Similar articles
-
Orchidectomy vs. Zoladex plus flutamide in patients with metastatic prostate cancer. The EORTC GU Group.Eur Urol. 1990;18 Suppl 3:34-40. doi: 10.1159/000463978. Eur Urol. 1990. PMID: 2151274 Clinical Trial.
-
Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86.Cancer. 1990 Sep 1;66(5 Suppl):1067-73. doi: 10.1002/cncr.1990.66.s5.1067. Cancer. 1990. PMID: 2144208 Clinical Trial.
-
A phase III trial of zoladex and flutamide versus orchiectomy in the treatment of patients with advanced carcinoma of the prostate.Cancer. 1990 Sep 1;66(5 Suppl):1058-66. doi: 10.1002/cncr.1990.66.s5.1058. Cancer. 1990. PMID: 2144207 Clinical Trial.
-
Southwest Oncology Group strategies in prostatic carcinoma.Semin Surg Oncol. 1995 Jan-Feb;11(1):60-4. doi: 10.1002/ssu.2980110109. Semin Surg Oncol. 1995. PMID: 7754277 Review.
-
[Recent multicenter study protocols in the USA for patients with metastatic prostatic carcinoma].Urologe A. 1995 Sep;34(5):382-8. Urologe A. 1995. PMID: 7483154 Review. German.
Cited by
-
Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions.Drugs. 1991 Feb;41(2):254-88. doi: 10.2165/00003495-199141020-00008. Drugs. 1991. PMID: 1709853 Review.
-
Maximal androgen blockade for advanced prostate cancer.Cochrane Database Syst Rev. 2000;1999(2):CD001526. doi: 10.1002/14651858.CD001526. Cochrane Database Syst Rev. 2000. PMID: 10796804 Free PMC article.
-
Cyproterone acetate monotherapy in advanced prostatic carcinoma.Int Urol Nephrol. 1997;29(2):213-20. doi: 10.1007/BF02551344. Int Urol Nephrol. 1997. PMID: 9241550
-
Flutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in advanced prostatic cancer.Drugs Aging. 1991 Mar;1(2):104-15. doi: 10.2165/00002512-199101020-00003. Drugs Aging. 1991. PMID: 1794008 Review.
-
Leuprorelin. A review of its pharmacology and therapeutic use in prostatic disorders.Drugs Aging. 1991 Nov-Dec;1(6):487-509. doi: 10.2165/00002512-199101060-00008. Drugs Aging. 1991. PMID: 1794035 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical